TriSalus Life Sciences, Inc.TLSINASDAQ

Revenue (LTM)

$45M

+53.4% YoY

Net Income (LTM)

$-39M

-18.0% YoY

Free Cash Flow

$-19M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	8	12↑47.6%	19↑49.3%	29↑59.0%	45↑53.4%
Gross Profit	7	10↑40.7%	16↑56.9%	25↑59.2%	38↑50.8%
Operating Income	-24	-36↓51.6%	-54↓49.5%	-36↑33.6%	-27↑25.5%
Net Income	-29	-47↓63.6%	-59↓25.8%	-33↑44.0%	-39↓18.0%
EBITDA	-24	-47↓98.4%	-59↓25.4%	-36↑38.3%	-27↑25.5%
EPS Diluted	-0.92	-1.59↓72.8%	-2.23↓40.3%	-1.25↑43.9%	-1.84↓47.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	30	9↓68.9%	12↑25.1%	9↓27.6%	20↑139.8%
Total Current Assets	35	17↓51.0%	21↑21.2%	21↓0.9%	32↑56.0%
Total Assets	38	22↓41.9%	25↑11.8%	24↓2.5%	35↑47.4%
Total Current Liabilities	6	32↑407.7%	15↓54.6%	10↓30.4%	11↑12.4%
Total Liabilities	7	34↑394.9%	52↑50.5%	50↓3.5%	69↑38.8%
Total Equity	31	-12↓139.9%	-27↓119.6%	-26↑4.3%	-34↓30.8%
Total Debt	0	2	2↓18.7%	24↑1381.4%	34↑45.8%
Net Debt	-30	-7↑75.4%	-10↓36.7%	15↑248.3%	14↓7.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-23	-32↓42.4%	-51↓56.5%	-41↑19.2%	-18↑55.9%
Capital Expenditure	-1	-1↑37.5%	-1↑25.2%	-0↑41.3%	-1↓166.1%
Free Cash Flow	-24	-33↓38.2%	-51↓54.6%	-41↑19.5%	-19↑54.0%
Stock-Based Comp	0	0↑237.6%	1↑281.0%	5↑288.1%	9↑67.8%
Net Change in Cash	26	-21↓179.9%	2↑111.9%	-3↓232.0%	12↑466.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance